Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG)

Affiliations

• ¹ Department of Pharmacology, Center for Genetic Medicine, Northwestern University, Chicago, IL.
• ² Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
• ³ Department of Medicine, Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY; 23andMe, Inc, Sunnyvale, CA.
• ⁴ Illumina, Inc, San Diego, CA.
• ⁵ Department of Pediatrics, University of Louisville, Louisville, KY.
• ⁶ Departments of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, MA.
• ⁷ Division of Cardiology, Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
• ⁸ Ambry Genetics, Aliso Viejo, CA.
• ⁹ Divisions of Human Genetics and Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, Columbus, OH.
• ¹⁰ Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR.
• ¹¹ Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
• ¹² Autism and Developmental Medicine Institute, Geisinger, Danville, PA.
• ¹³ Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, MA.
• ¹⁴ American College of Medical Genetics and Genomics, Bethesda, MD.